Home › Cystic Fibrosis › Wisconsin › Madison
Cystic Fibrosis clinical trials in Madison, WI
5 studies for Cystic Fibrosis are looking for participants at sites in and around Madison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
RecruitingPhase 2
- University of Wisconsin, Madison
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Recruiting
- University of Wisconsin, Madison
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
RecruitingObservational study
- University of Wisconsin, Madison
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
RecruitingPhase 4
- University of Wisconsin, Madison
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RecruitingObservational study
- University of Wisconsin, Madison
About Cystic Fibrosis
Cystic fibrosis (CF) is an inherited disease of the mucus and sweat glands. The symptoms and severity of CF can vary. Get the facts.
More about Cystic Fibrosis on MedlinePlus
Cystic Fibrosis trials in other cities
- Boston, MA17 studies
- Birmingham, AL16 studies
- Philadelphia, PA15 studies
- Kansas City, KS13 studies
- Seattle, WA12 studies
- Baltimore, MD12 studies
- Denver, CO11 studies
- Pittsburgh, PA11 studies
- Dallas, TX11 studies
- Cincinnati, OH10 studies
- Los Angeles, CA9 studies
- Aurora, CO9 studies
Other studies in Madison
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Breast Cancer22 studies
- Metastatic Cancer21 studies
- Acute Myeloid Leukemia16 studies
- Non-Small Cell Lung Cancer16 studies
- Melanoma15 studies
- Cancer (all types)14 studies
- Ovarian Cancer13 studies
- Stomach Cancer11 studies
- Pancreatic Cancer10 studies
- Lung Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.